parthenolide has been researched along with Carcinoma, Epidermoid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, WC; Chen, BK; Huang, CR; Ko, SC; Shieh, JM; Yang, JH | 1 |
Cole, JR; Hoffmann, JJ; Torrance, SJ; Widehopf, RM | 1 |
2 other study(ies) available for parthenolide and Carcinoma, Epidermoid
Article | Year |
---|---|
Epidermal growth factor protects squamous cell carcinoma against cisplatin-induced cytotoxicity through increased interleukin-1β expression.
Topics: Biomarkers, Tumor; Blotting, Western; Carcinoma, Squamous Cell; Chromones; Cisplatin; Cytotoxins; DNA Primers; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; ErbB Receptors; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1beta; Morpholines; NF-kappa B; Oncogene Protein v-akt; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Sesquiterpenes; Signal Transduction | 2013 |
Cytotoxic agents from Michelia champaca and Talauma ovata: parthenolide and costunolide.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Humans; Neoplasms, Experimental; Phytotherapy; Plants, Medicinal; Sesquiterpenes | 1977 |